<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04829058</url>
  </required_header>
  <id_info>
    <org_study_id>ESC_2020_02</org_study_id>
    <nct_id>NCT04829058</nct_id>
  </id_info>
  <brief_title>GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study</brief_title>
  <official_title>A Retrospective and Long-Term Prospective Post Market Clinical Follow-up (PMCF) Study of the GYNECARE GYNEMESH® PS Nonabsorbable PROLENE® Soft Mesh</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this retrospective and prospective, single-arm, observational, multicenter,&#xD;
      post-market study is to evaluate outcomes in women who underwent surgery for vaginal or&#xD;
      uterine prolapse with a GYNEMESH PS Mesh.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 30, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2029</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2029</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Physical examination with Pelvic Organ Prolapse Quantification (POP-Q) Assessment CHange</measure>
    <time_frame>Post-surgery through study completion, approximately 7 yrs</time_frame>
    <description>Objective cure of vaginal or uterine prolapse approximately 7 years after surgery, defined as POP-Q stage ≤2 at point C as determined with physical exam.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Improvement (PGI-I) or Patient Global Impression of Change (PGI-C) Questionnaire</measure>
    <time_frame>Post-surgery through study completion, approximately 7yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Floor Distress Inventory (PFDI-20) Questionnaire</measure>
    <time_frame>Post-surgery through study completion, approximately 7yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) or Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR)</measure>
    <time_frame>Post-surgery through study completion, approximately 7yrs</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention</intervention_name>
    <description>There is no intervention, beyond necessary clinical care, in this study. The surgical procedures that were performed in subjects within this study are identical to the surgical procedures the subjects would have received as part of SOC.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Female subjects ≥ 21 years of age:&#xD;
&#xD;
          -  with a baseline diagnosis of apical vaginal or uterine prolapse;&#xD;
&#xD;
          -  who had laparotomic or laparoscopic sacrocolpopexy, including robotic-assisted, for&#xD;
             apical vaginal or uterine prolapse within 7 years of enrolment;&#xD;
&#xD;
          -  where GYNEMESH PS Mesh was used as a bridging material, and;&#xD;
&#xD;
          -  who are willing and able to participate in prospective follow-up.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Subjects who satisfy all of the following criteria will be considered eligible for&#xD;
        enrollment in this study:&#xD;
&#xD;
          1. Female subjects who had laparotomic or laparoscopic abdominal sacrocolpopexy,&#xD;
             including robotic-assisted, for apical vaginal or uterine prolapse&#xD;
&#xD;
          2. GYNEMESH PS Mesh was used as a bridging material according to the IFU.&#xD;
&#xD;
          3. Able and willing to participate in follow-up&#xD;
&#xD;
          4. Subject or authorized representative has signed the approved informed consent&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        Subjects meeting any of the following criteria will be considered not eligible for&#xD;
        enrollment in this study:&#xD;
&#xD;
          1. Subjects &lt; 21 years of age at the time of informed consent&#xD;
&#xD;
          2. Subjects who had transvaginal approach for surgery&#xD;
&#xD;
          3. Had undergone a uterus-sparing procedure (sacrohystero or sacrocervicopexy)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female subjects ≥ 21 years of age</gender_description>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni A Tommaselli, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ethicon, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine Romanowski</last_name>
    <phone>908-218-3156</phone>
    <email>cromanow@its.jnj.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute for Female Pelvic Medicine</name>
      <address>
        <city>North Wales</city>
        <state>Pennsylvania</state>
        <zip>19454</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>UMPC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Tubingen</name>
      <address>
        <city>Tubingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 19, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GYNECARE GYNEMESH® PS Nonabsorbable PROLENE® Soft Mesh</keyword>
  <keyword>POP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Johnson &amp; Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.</ipd_description>
    <ipd_url>http://yoda.yale.edu</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

